GUERBET (GBT.PA) Fundamental Analysis & Valuation

EPA:GBT • FR0000032526

Current stock price

11.62 EUR
+1.52 (+15.05%)
Last:

This GBT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. GBT.PA Profitability Analysis

1.1 Basic Checks

  • In the past year GBT has reported negative net income.
  • GBT had a positive operating cash flow in the past year.
  • In multiple years GBT reported negative net income over the last 5 years.
  • GBT had a positive operating cash flow in each of the past 5 years.
GBT.PA Yearly Net Income VS EBIT VS OCF VS FCFGBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • GBT has a worse Return On Assets (-11.65%) than 70.49% of its industry peers.
  • With a Return On Equity value of -40.57%, GBT is not doing good in the industry: 75.41% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -11.65%
ROE -40.57%
ROIC N/A
ROA(3y)-2.59%
ROA(5y)-1.78%
ROE(3y)-10.06%
ROE(5y)-6.59%
ROIC(3y)N/A
ROIC(5y)N/A
GBT.PA Yearly ROA, ROE, ROICGBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30 -40

1.3 Margins

  • In the last couple of years the Operating Margin of GBT has declined.
  • The Gross Margin of GBT (75.59%) is better than 88.52% of its industry peers.
  • In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
  • GBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.59%
OM growth 3Y-43.49%
OM growth 5Y-29.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.42%
GBT.PA Yearly Profit, Operating, Gross MarginsGBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. GBT.PA Health Analysis

2.1 Basic Checks

  • GBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for GBT remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for GBT remains at a similar level compared to 5 years ago.
  • Compared to 1 year ago, GBT has a worse debt to assets ratio.
GBT.PA Yearly Shares OutstandingGBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
GBT.PA Yearly Total Debt VS Total AssetsGBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of 1.59, we must say that GBT is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of GBT (1.59) is worse than 68.85% of its industry peers.
  • GBT has a debt to FCF ratio of 9.84. This is a negative value and a sign of low solvency as GBT would need 9.84 years to pay back of all of its debts.
  • GBT has a Debt to FCF ratio (9.84) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.47 is on the high side and indicates that GBT has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.47, GBT is not doing good in the industry: 78.69% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 9.84
Altman-Z 1.59
ROIC/WACCN/A
WACC6.24%
GBT.PA Yearly LT Debt VS Equity VS FCFGBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • GBT has a Current Ratio of 2.49. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.49, GBT is in the better half of the industry, outperforming 68.85% of the companies in the same industry.
  • GBT has a Quick Ratio of 1.27. This is a normal value and indicates that GBT is financially healthy and should not expect problems in meeting its short term obligations.
  • GBT has a Quick ratio (1.27) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.49
Quick Ratio 1.27
GBT.PA Yearly Current Assets VS Current LiabilitesGBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. GBT.PA Growth Analysis

3.1 Past

  • The earnings per share for GBT have decreased strongly by -769.32% in the last year.
  • Looking at the last year, GBT shows a decrease in Revenue. The Revenue has decreased by -6.50% in the last year.
  • Measured over the past years, GBT shows a small growth in Revenue. The Revenue has been growing by 2.00% on average per year.
EPS 1Y (TTM)-769.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2277.6%
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y1.45%
Revenue growth 5Y2%
Sales Q2Q%-5.5%

3.2 Future

  • Based on estimates for the next years, GBT will show a very strong growth in Earnings Per Share. The EPS will grow by 100.64% on average per year.
  • Based on estimates for the next years, GBT will show a small growth in Revenue. The Revenue will grow by 1.03% on average per year.
EPS Next Y-417.31%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
EPS Next 5YN/A
Revenue Next Year-5.17%
Revenue Next 2Y0.06%
Revenue Next 3Y1.03%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GBT.PA Yearly Revenue VS EstimatesGBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
GBT.PA Yearly EPS VS EstimatesGBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

3

4. GBT.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GBT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GBT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GBT.PA Price Earnings VS Forward Price EarningsGBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

  • GBT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GBT is cheaper than 95.08% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.3
EV/EBITDA 4.84
GBT.PA Per share dataGBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • A more expensive valuation may be justified as GBT's earnings are expected to grow with 100.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y275.2%
EPS Next 3Y100.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. GBT.PA Dividend Analysis

5.1 Amount

  • GBT has a Yearly Dividend Yield of 2.69%.
  • GBT's Dividend Yield is rather good when compared to the industry average which is at 1.26. GBT pays more dividend than 81.97% of the companies in the same industry.
  • GBT's Dividend Yield is a higher than the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
GBT.PA Yearly Dividends per shareGBT.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

DP0%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
GBT.PA Yearly Income VS Free CF VS DividendGBT.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

More info and screens

Find the best dividend stocksShow peers with best dividend

GBT.PA Fundamentals: All Metrics, Ratios and Statistics

GUERBET

EPA:GBT (4/24/2026, 7:00:00 PM)

11.62

+1.52 (+15.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-23
Earnings (Next)07-23
Inst Owners8.83%
Inst Owner ChangeN/A
Ins Owners5.01%
Ins Owner ChangeN/A
Market Cap146.88M
Revenue(TTM)786.44M
Net Income(TTM)-108.33M
Analysts44
Price Target12.19 (4.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.81%
PT rev (3m)-8.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-78.86%
EPS NY rev (3m)-138.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.15%
Revenue NY rev (3m)-8.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF 3.3
P/OCF 1.81
P/B 0.55
P/tB 0.71
EV/EBITDA 4.84
EPS(TTM)-8.5
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)3.52
FCFY30.28%
OCF(TTM)6.42
OCFY55.21%
SpS62.22
BVpS21.12
TBVpS16.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -11.65%
ROE -40.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.59%
FCFM 5.66%
ROA(3y)-2.59%
ROA(5y)-1.78%
ROE(3y)-10.06%
ROE(5y)-6.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.11%
ROCE(5y)4.72%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-43.49%
OM growth 5Y-29.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.42%
F-Score4
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 9.84
Debt/EBITDA 5.29
Cap/Depr 22.55%
Cap/Sales 4.66%
Interest Coverage N/A
Cash Conversion 109.34%
Profit Quality N/A
Current Ratio 2.49
Quick Ratio 1.27
Altman-Z 1.59
F-Score4
WACC6.24%
ROIC/WACCN/A
Cap/Depr(3y)65.96%
Cap/Depr(5y)64.56%
Cap/Sales(3y)6.22%
Cap/Sales(5y)6.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-769.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2277.6%
EPS Next Y-417.31%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y1.45%
Revenue growth 5Y2%
Sales Q2Q%-5.5%
Revenue Next Year-5.17%
Revenue Next 2Y0.06%
Revenue Next 3Y1.03%
Revenue Next 5YN/A
EBIT growth 1Y-277.86%
EBIT growth 3Y-42.67%
EBIT growth 5Y-28.34%
EBIT Next Year317.55%
EBIT Next 3Y81.45%
EBIT Next 5YN/A
FCF growth 1Y83.59%
FCF growth 3YN/A
FCF growth 5Y-6.04%
OCF growth 1Y-0.16%
OCF growth 3Y38.62%
OCF growth 5Y-7.61%

GUERBET / GBT.PA Fundamental Analysis FAQ

What is the fundamental rating for GBT stock?

ChartMill assigns a fundamental rating of 3 / 10 to GBT.PA.


What is the valuation status of GUERBET (GBT.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to GUERBET (GBT.PA). This can be considered as Overvalued.


Can you provide the profitability details for GUERBET?

GUERBET (GBT.PA) has a profitability rating of 2 / 10.


Can you provide the financial health for GBT stock?

The financial health rating of GUERBET (GBT.PA) is 3 / 10.


Can you provide the expected EPS growth for GBT stock?

The Earnings per Share (EPS) of GUERBET (GBT.PA) is expected to decline by -417.31% in the next year.